C. Gourguechon
Impact in
-
- Rheumatoid Arthritis Research and Therapies
- Otitis Media and Relapsing Polychondritis
-
- Acute Myeloid Leukemia Research
Papers in
-
- Rheumatoid Arthritis Research and Therapies 2
-
- Platelet Disorders and Treatments 2
- Hemophilia Treatment and Research 1
- Blood groups and transfusion 1
- Co-authors
- C. Brault (4 shared papers)Caroline Guignant (1 shared paper)Jean‐Pierre Marolleau (2 shared papers)Pierre Morel (1 shared paper)Patrice Fardellone (1 shared paper)Brigitte Gubler (1 shared paper)Vincent Goëb (1 shared paper)Matthieu Ponsoye (1 shared paper)
- Journals
- British Journal of Haematology (1 paper)Blood Advances (1 paper)Arthritis Research & Therapy (1 paper)Blood (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
C. Gourguechon
11 papers receiving 77 citations
Peers
Comparison fields: 5 of 30
- Rheumatology 25
- Hematology 19
- Immunology 29
- Ophthalmology 6
- Genetics 7
Countries citing papers authored by C. Gourguechon
This map shows the geographic impact of C. Gourguechon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gourguechon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gourguechon more than expected).
Fields of papers citing papers by C. Gourguechon
This network shows the impact of papers produced by C. Gourguechon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gourguechon. The network helps show where C. Gourguechon may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Gourguechon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 39 | |
| 2 | 2018 | 23 | |
| 3 | 2019 | 4 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2020 | 1 | |
| 8 | 2017 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2017 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2021 | 0 | |
| 14 | 2016 | 0 |
About C. Gourguechon
C. Gourguechon is a scholar working on Rheumatology, Hematology, Immunology, Surgery and Genetics, having authored 14 papers that have together received 78 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Hemophilia Treatment and Research (1 paper), Metabolism and Genetic Disorders (1 paper), Healthcare Systems and Practices (1 paper), Blood groups and transfusion (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Rheumatology (25 citations), Hematology (19 citations), Immunology (29 citations), Ophthalmology (6 citations) and Genetics (7 citations). C. Gourguechon has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include C. Brault, Caroline Guignant, Jean‐Pierre Marolleau, Pierre Morel, Patrice Fardellone, Brigitte Gubler, Vincent Goëb, Matthieu Ponsoye, Pierre Fenaux and Jérôme Gillard. Their work appears in journals such as British Journal of Haematology, Blood Advances, Arthritis Research & Therapy, Blood and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.